Richard Graydon
Chief Tech/Sci/R&D Officer bei ATOSSA THERAPEUTICS, INC.
Profil
Dr. Richard Graydon is a Chief Medical Officer at Atossa Therapeutics, Inc. Dr. Graydon was previously employed as a Director-Clinical Development by Daiichi Sankyo, Inc. He received his undergraduate degree from Cornell University and a doctorate degree from Stanford University.
Aktive Positionen von Richard Graydon
Unternehmen | Position | Beginn |
---|---|---|
ATOSSA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 25.10.2022 |
Ehemalige bekannte Positionen von Richard Graydon
Unternehmen | Position | Ende |
---|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Richard Graydon
Stanford University | Doctorate Degree |
Cornell University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ATOSSA THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |